Streetbeat News

Stock Prices

BCYC

Bicycle Therapeutics shares are trading lower following the announcement of updated Phase 1/2 clinical results for their Bicycle Toxin Conjugate zelenectide pevedotin in metastatic urothelial cancer, BTC molecule BT5528 in advanced solid tumors, and Bicycle Tumor-Targeted Immune Cell Agonist BT7480 in advanced solid tumors.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:44 pm

AXR

AMREP shares rose after the company reported its Q1 earnings late Friday.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:41 pm

STRO

Sutro Biopharma's shares are declining following the release of updated data from their Phase 1b study of luveltamab tazevibulin in combination with bevacizumab for epithelial ovarian cancer, presented at the 2024 ESMO Congress.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:39 pm

SNOA

Sonoma Pharmaceuticals' stock is rising following the FDA's 510(k) clearance for its microdacyn wound care solution, indicating potential growth and increased market presence.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:39 pm

SBT

Sterling Bancorp shares fell after announcing the sale of Sterling Bank and Trust F.S.B. to EverBank Financial Corp. The company plans to dissolve and wind down operations post-sale.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:36 pm

IP

PKG

Cascades announced a containerboard price increase effective October 7, leading to a spike in the share prices of Packaging Corporation of America (PKG) and International Paper (IP). The price increase includes $40/ton for linerboard, $70/ton for corrugating medium, and $40/ton for white-top linerboard. Traders speculate that other containerboard manufacturers might follow suit.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:33 pm

PLCE

Children's Place, Inc. (NASDAQ:PLCE) shares are pulling back after a significant rise due to a second-quarter earnings beat. Despite a decline in sales, profitability improved due to cost-cutting, and store sales saw positive growth for the first time since 2021. The stock remains volatile with a high short interest.

Portfolio Pulse from Erica Kollmann

September 16, 2024 | 7:32 pm

MSTR

Financial giants have shown a bullish interest in MicroStrategy (NASDAQ:MSTR) options, with 145 unusual trades identified. Despite a recent price drop, analysts have mixed ratings, with a consensus target price of $171.0. The stock's RSI suggests it may be nearing overbought territory.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:15 pm

UNH

Deep-pocketed investors are showing a bearish sentiment towards UnitedHealth Group (NYSE:UNH) as revealed by Benzinga's options scanner. The options activity is unusual, with 34 significant trades, including 10 puts and 24 calls. The price target for UNH is between $350 and $640. The stock is currently down 0.48% at $589.39, and analysts have set an average price target of $591.0.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:15 pm

REPL

Replimune Group's shares are declining following the announcement of primary analysis results from its IGNYTE clinical trial of PR1 in combination with Nivulumab for anti-PBD resistant melanoma at the 2024 ESMO Congress.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:12 pm